Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Inventory (2016 - 2026)

Integra Lifesciences Holdings' Inventory history spans 17 years, with the latest figure at $492.7 million for Q4 2025.

  • On a quarterly basis, Inventory rose 14.83% to $492.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $492.7 million, a 14.83% increase, with the full-year FY2025 number at $492.7 million, up 14.83% from a year prior.
  • Inventory hit $492.7 million in Q4 2025 for Integra Lifesciences Holdings, up from $489.1 million in the prior quarter.
  • Over the last five years, Inventory for IART hit a ceiling of $492.7 million in Q4 2025 and a floor of $311.1 million in Q3 2022.
  • Historically, Inventory has averaged $381.3 million across 5 years, with a median of $360.3 million in 2023.
  • Biggest five-year swings in Inventory: dropped 9.79% in 2021 and later rose 20.03% in 2023.
  • Tracing IART's Inventory over 5 years: stood at $317.4 million in 2021, then rose by 2.27% to $324.6 million in 2022, then rose by 20.03% to $389.6 million in 2023, then grew by 10.13% to $429.1 million in 2024, then increased by 14.83% to $492.7 million in 2025.
  • Business Quant data shows Inventory for IART at $492.7 million in Q4 2025, $489.1 million in Q3 2025, and $465.1 million in Q2 2025.